Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Percutaneous Coronary Intervention | 30 | 2025 | 206 | 12.820 |
Why?
|
Coronary Artery Disease | 18 | 2025 | 308 | 9.480 |
Why?
|
Shock, Cardiogenic | 6 | 2025 | 99 | 4.920 |
Why?
|
Drug-Eluting Stents | 7 | 2023 | 62 | 4.570 |
Why?
|
ST Elevation Myocardial Infarction | 10 | 2025 | 87 | 4.430 |
Why?
|
Myocardial Infarction | 10 | 2025 | 909 | 3.620 |
Why?
|
Cardiac Catheterization | 10 | 2020 | 278 | 3.540 |
Why?
|
Coronary Angiography | 14 | 2025 | 200 | 2.980 |
Why?
|
Coronary Artery Bypass | 11 | 2023 | 297 | 2.170 |
Why?
|
Registries | 11 | 2025 | 869 | 2.130 |
Why?
|
Coronary Stenosis | 4 | 2025 | 39 | 2.030 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2018 | 19 | 1.930 |
Why?
|
Treatment Outcome | 28 | 2025 | 5555 | 1.890 |
Why?
|
Hospital Mortality | 5 | 2025 | 864 | 1.830 |
Why?
|
Coronary Vessel Anomalies | 4 | 2021 | 21 | 1.720 |
Why?
|
Coronary Vessels | 4 | 2019 | 118 | 1.580 |
Why?
|
Stents | 7 | 2025 | 485 | 1.560 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 186 | 1.540 |
Why?
|
Retrospective Studies | 22 | 2025 | 6487 | 1.450 |
Why?
|
Time-to-Treatment | 3 | 2025 | 108 | 1.450 |
Why?
|
Heart Failure | 4 | 2022 | 899 | 1.220 |
Why?
|
Catheterization, Peripheral | 2 | 2019 | 53 | 1.210 |
Why?
|
Humans | 56 | 2025 | 62518 | 1.160 |
Why?
|
Hemodynamics | 3 | 2025 | 242 | 1.110 |
Why?
|
Mortality | 2 | 2019 | 160 | 1.040 |
Why?
|
Male | 33 | 2025 | 29379 | 1.000 |
Why?
|
Vascular Diseases | 3 | 2021 | 81 | 0.950 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2021 | 168 | 0.940 |
Why?
|
Coronary Circulation | 1 | 2025 | 51 | 0.920 |
Why?
|
Acute Coronary Syndrome | 2 | 2023 | 253 | 0.910 |
Why?
|
Radial Artery | 4 | 2020 | 53 | 0.910 |
Why?
|
Heart-Assist Devices | 2 | 2024 | 142 | 0.900 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2025 | 49 | 0.900 |
Why?
|
Models, Cardiovascular | 1 | 2025 | 78 | 0.890 |
Why?
|
Coronary Thrombosis | 3 | 2018 | 20 | 0.880 |
Why?
|
Ultrasonography, Interventional | 2 | 2015 | 99 | 0.840 |
Why?
|
Risk Factors | 14 | 2023 | 5289 | 0.830 |
Why?
|
Radiologists | 3 | 2019 | 88 | 0.800 |
Why?
|
Middle Aged | 22 | 2025 | 17297 | 0.800 |
Why?
|
Respiration, Artificial | 1 | 2025 | 295 | 0.780 |
Why?
|
Female | 27 | 2025 | 32388 | 0.770 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2023 | 225 | 0.760 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 142 | 0.740 |
Why?
|
Anemia | 1 | 2023 | 126 | 0.740 |
Why?
|
Cardiology | 2 | 2020 | 167 | 0.720 |
Why?
|
Cardiologists | 2 | 2019 | 28 | 0.720 |
Why?
|
Aged | 16 | 2025 | 14205 | 0.710 |
Why?
|
Atherosclerosis | 1 | 2022 | 152 | 0.710 |
Why?
|
Hirudins | 2 | 2019 | 12 | 0.680 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 164 | 0.680 |
Why?
|
Middle East | 3 | 2025 | 10 | 0.660 |
Why?
|
Ankle Brachial Index | 1 | 2019 | 13 | 0.660 |
Why?
|
Myocardial Revascularization | 2 | 2022 | 75 | 0.650 |
Why?
|
Ticlopidine | 2 | 2011 | 48 | 0.650 |
Why?
|
Saphenous Vein | 1 | 2020 | 52 | 0.650 |
Why?
|
Aneurysm | 1 | 2020 | 60 | 0.630 |
Why?
|
Heparin | 2 | 2019 | 116 | 0.630 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2020 | 56 | 0.630 |
Why?
|
Chest Pain | 1 | 2019 | 83 | 0.620 |
Why?
|
Exercise Test | 2 | 2019 | 249 | 0.610 |
Why?
|
Angina, Stable | 2 | 2016 | 11 | 0.600 |
Why?
|
Betacoronavirus | 1 | 2020 | 177 | 0.590 |
Why?
|
Peptide Fragments | 2 | 2019 | 411 | 0.580 |
Why?
|
Cardiology Service, Hospital | 1 | 2017 | 17 | 0.570 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 535 | 0.560 |
Why?
|
Patient Care Team | 2 | 2017 | 335 | 0.560 |
Why?
|
Coronavirus Infections | 1 | 2020 | 202 | 0.540 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 216 | 0.540 |
Why?
|
Blood Pressure | 2 | 2018 | 513 | 0.510 |
Why?
|
Tomography, Optical Coherence | 2 | 2020 | 223 | 0.500 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2015 | 16 | 0.480 |
Why?
|
Thrombosis | 1 | 2017 | 199 | 0.470 |
Why?
|
Bradycardia | 1 | 2015 | 33 | 0.470 |
Why?
|
Cicatrix | 1 | 2015 | 61 | 0.470 |
Why?
|
Hemorrhage | 3 | 2023 | 266 | 0.460 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 28 | 0.460 |
Why?
|
Incidence | 5 | 2020 | 1359 | 0.450 |
Why?
|
After-Hours Care | 1 | 2014 | 7 | 0.450 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2015 | 108 | 0.450 |
Why?
|
Candidiasis | 1 | 2014 | 51 | 0.440 |
Why?
|
Endocarditis | 1 | 2014 | 28 | 0.440 |
Why?
|
Embolism | 1 | 2014 | 41 | 0.440 |
Why?
|
Severity of Illness Index | 6 | 2021 | 1538 | 0.430 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 217 | 0.400 |
Why?
|
Residence Characteristics | 1 | 2014 | 220 | 0.400 |
Why?
|
Consensus | 3 | 2020 | 224 | 0.390 |
Why?
|
Renal Circulation | 1 | 2012 | 13 | 0.390 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2012 | 8 | 0.390 |
Why?
|
Thrombectomy | 1 | 2014 | 227 | 0.380 |
Why?
|
Ischemic Preconditioning | 1 | 2012 | 8 | 0.380 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2012 | 28 | 0.380 |
Why?
|
Reperfusion Injury | 1 | 2012 | 53 | 0.370 |
Why?
|
Coronary Restenosis | 1 | 2011 | 20 | 0.370 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 1076 | 0.370 |
Why?
|
Endpoint Determination | 1 | 2011 | 25 | 0.370 |
Why?
|
Stroke Volume | 2 | 2022 | 327 | 0.340 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 267 | 0.340 |
Why?
|
Aspirin | 1 | 2011 | 171 | 0.330 |
Why?
|
Heart Valve Prosthesis | 1 | 2011 | 107 | 0.330 |
Why?
|
Massachusetts | 5 | 2019 | 2061 | 0.330 |
Why?
|
Physicians | 1 | 2014 | 464 | 0.300 |
Why?
|
Heptanoic Acids | 1 | 2008 | 22 | 0.290 |
Why?
|
Pyrroles | 1 | 2008 | 50 | 0.290 |
Why?
|
Physician's Role | 2 | 2019 | 124 | 0.270 |
Why?
|
Electrocardiography | 3 | 2020 | 548 | 0.240 |
Why?
|
Ultrasonography, Doppler | 1 | 2025 | 27 | 0.240 |
Why?
|
Hydrodynamics | 1 | 2025 | 36 | 0.230 |
Why?
|
Prospective Studies | 5 | 2020 | 3246 | 0.230 |
Why?
|
Time Factors | 3 | 2025 | 3737 | 0.230 |
Why?
|
Prevalence | 2 | 2020 | 1343 | 0.220 |
Why?
|
Prognosis | 3 | 2018 | 1717 | 0.220 |
Why?
|
Dissection | 2 | 2021 | 48 | 0.220 |
Why?
|
Atrial Fibrillation | 1 | 2011 | 831 | 0.210 |
Why?
|
Computational Biology | 1 | 2025 | 352 | 0.200 |
Why?
|
Follow-Up Studies | 3 | 2018 | 2440 | 0.200 |
Why?
|
Multivariate Analysis | 3 | 2016 | 928 | 0.200 |
Why?
|
Stroke | 1 | 2011 | 1184 | 0.200 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 137 | 0.190 |
Why?
|
Reproducibility of Results | 2 | 2018 | 1637 | 0.190 |
Why?
|
Dobutamine | 1 | 2021 | 9 | 0.190 |
Why?
|
Echocardiography | 1 | 2025 | 498 | 0.180 |
Why?
|
Job Description | 2 | 2019 | 24 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 1582 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2024 | 452 | 0.180 |
Why?
|
Unemployment | 1 | 2021 | 18 | 0.180 |
Why?
|
Kidney | 1 | 2023 | 444 | 0.180 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 727 | 0.170 |
Why?
|
Non-ST Elevated Myocardial Infarction | 1 | 2020 | 32 | 0.170 |
Why?
|
Oxygen | 2 | 2020 | 316 | 0.170 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2020 | 33 | 0.170 |
Why?
|
Recombinant Proteins | 2 | 2019 | 700 | 0.170 |
Why?
|
Aortic Valve | 1 | 2021 | 187 | 0.160 |
Why?
|
Arterial Occlusive Diseases | 1 | 2020 | 74 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2018 | 562 | 0.160 |
Why?
|
Antithrombins | 1 | 2019 | 15 | 0.160 |
Why?
|
Global Health | 1 | 2020 | 182 | 0.150 |
Why?
|
Clinical Decision-Making | 1 | 2020 | 159 | 0.150 |
Why?
|
Radiology, Interventional | 1 | 2019 | 32 | 0.150 |
Why?
|
Hemostatic Techniques | 1 | 2018 | 11 | 0.150 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2018 | 6 | 0.150 |
Why?
|
Ischemic Attack, Transient | 1 | 2019 | 96 | 0.150 |
Why?
|
Hyperoxia | 1 | 2018 | 17 | 0.150 |
Why?
|
Punctures | 1 | 2018 | 64 | 0.150 |
Why?
|
Femoral Artery | 1 | 2019 | 110 | 0.150 |
Why?
|
Risk Assessment | 3 | 2017 | 2033 | 0.150 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 169 | 0.150 |
Why?
|
Decision Support Techniques | 1 | 2020 | 194 | 0.150 |
Why?
|
Stress, Physiological | 1 | 2019 | 193 | 0.140 |
Why?
|
Postoperative Complications | 2 | 2017 | 1261 | 0.140 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2017 | 24 | 0.140 |
Why?
|
Widowhood | 1 | 2017 | 5 | 0.140 |
Why?
|
Logistic Models | 3 | 2017 | 1272 | 0.140 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 104 | 0.140 |
Why?
|
Vascular Surgical Procedures | 1 | 2019 | 257 | 0.140 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 414 | 0.140 |
Why?
|
Referral and Consultation | 2 | 2017 | 421 | 0.130 |
Why?
|
Constriction, Pathologic | 1 | 2017 | 120 | 0.130 |
Why?
|
Heart Diseases | 1 | 2019 | 215 | 0.130 |
Why?
|
Clinical Competence | 2 | 2019 | 711 | 0.130 |
Why?
|
Cooperative Behavior | 1 | 2017 | 220 | 0.130 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 190 | 0.120 |
Why?
|
Theophylline | 1 | 2015 | 10 | 0.120 |
Why?
|
Pandemics | 1 | 2020 | 661 | 0.120 |
Why?
|
Treatment Refusal | 1 | 2015 | 55 | 0.120 |
Why?
|
Adult | 5 | 2021 | 16571 | 0.120 |
Why?
|
Algorithms | 1 | 2020 | 1003 | 0.120 |
Why?
|
Polysomnography | 1 | 2015 | 57 | 0.120 |
Why?
|
Inpatients | 1 | 2017 | 300 | 0.120 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 103 | 0.120 |
Why?
|
Suction | 1 | 2014 | 34 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 463 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2014 | 122 | 0.110 |
Why?
|
Prosthesis Design | 1 | 2015 | 223 | 0.110 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2014 | 64 | 0.110 |
Why?
|
Antifungal Agents | 1 | 2014 | 126 | 0.110 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 365 | 0.110 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2014 | 168 | 0.110 |
Why?
|
Cohort Studies | 1 | 2019 | 2530 | 0.100 |
Why?
|
Pregnancy | 1 | 2020 | 2309 | 0.100 |
Why?
|
Anticoagulants | 1 | 2017 | 493 | 0.100 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 1139 | 0.100 |
Why?
|
Practice Patterns, Physicians' | 1 | 2017 | 706 | 0.100 |
Why?
|
Troponin | 1 | 2012 | 38 | 0.090 |
Why?
|
Creatinine | 1 | 2012 | 134 | 0.090 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 2530 | 0.090 |
Why?
|
Sirolimus | 1 | 2011 | 91 | 0.090 |
Why?
|
Paclitaxel | 1 | 2011 | 100 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2011 | 148 | 0.090 |
Why?
|
Pericardial Effusion | 1 | 2010 | 21 | 0.090 |
Why?
|
Hepatitis B | 1 | 2010 | 32 | 0.090 |
Why?
|
Patients | 1 | 2011 | 110 | 0.080 |
Why?
|
Immunosuppressive Agents | 1 | 2011 | 376 | 0.080 |
Why?
|
United States | 2 | 2018 | 7697 | 0.080 |
Why?
|
Myocardium | 1 | 2010 | 274 | 0.070 |
Why?
|
Hepatitis C | 1 | 2010 | 151 | 0.070 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2008 | 29 | 0.070 |
Why?
|
Health Behavior | 1 | 2011 | 466 | 0.070 |
Why?
|
Obesity | 1 | 2015 | 1228 | 0.070 |
Why?
|
Health Promotion | 1 | 2011 | 491 | 0.070 |
Why?
|
Liver | 1 | 2010 | 838 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 752 | 0.060 |
Why?
|
Odds Ratio | 2 | 2017 | 768 | 0.060 |
Why?
|
Cardiovascular Diseases | 1 | 2011 | 831 | 0.050 |
Why?
|
Wrist | 1 | 2020 | 37 | 0.040 |
Why?
|
Arabs | 1 | 2019 | 8 | 0.040 |
Why?
|
Hematoma | 1 | 2020 | 77 | 0.040 |
Why?
|
Infusions, Intra-Arterial | 1 | 2018 | 13 | 0.040 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 70 | 0.040 |
Why?
|
Specialization | 1 | 2019 | 81 | 0.040 |
Why?
|
Workload | 1 | 2019 | 121 | 0.040 |
Why?
|
Needs Assessment | 1 | 2019 | 196 | 0.040 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 207 | 0.040 |
Why?
|
Saudi Arabia | 1 | 2017 | 7 | 0.030 |
Why?
|
United Arab Emirates | 1 | 2017 | 4 | 0.030 |
Why?
|
Tertiary Care Centers | 1 | 2017 | 104 | 0.030 |
Why?
|
Leadership | 1 | 2019 | 203 | 0.030 |
Why?
|
Animals | 1 | 2015 | 20566 | 0.030 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 338 | 0.030 |
Why?
|
Survival Rate | 1 | 2017 | 838 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 775 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2016 | 174 | 0.030 |
Why?
|
Sex Factors | 1 | 2017 | 969 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2016 | 315 | 0.030 |
Why?
|
Patient Selection | 1 | 2016 | 481 | 0.030 |
Why?
|
Age Factors | 1 | 2016 | 1553 | 0.020 |
Why?
|
Coronary Disease | 1 | 2011 | 246 | 0.020 |
Why?
|
Cholesterol | 1 | 2011 | 259 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 2145 | 0.020 |
Why?
|
Biopsy | 1 | 2010 | 429 | 0.020 |
Why?
|
Heart | 1 | 2010 | 281 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 861 | 0.020 |
Why?
|
Smoking | 1 | 2011 | 864 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 5390 | 0.020 |
Why?
|
Hypertension | 1 | 2011 | 590 | 0.020 |
Why?
|
Exercise | 1 | 2011 | 936 | 0.010 |
Why?
|